IL4I1 and cancer: IL4I1, a metabolic immune checkpoint that activates the aryl hydrocarbon receptor (AHR) through the generation of indole metabolites and kynurenic acid, has been shown to promote cancer cell mobility and metastasis and to suppress anti-tumor immunity32.